非洲人现在同样热衷于亚洲药物：青蒿素，一种从中国灌木中提取的、非常有效的治疗疟疾的药物。
Africans are now just as keen on Asian medicine: artemisinin, a highly effective malaria remedy derived from a Chinese shrub.
这些组织也投资于抗疟疾药物开发，基于青蒿素的组合疗法。
The groups have also invested in antimalaria drugs for A.C.T., artemisinin-based combination therapy.
青蒿素还是一种有前途的有效药物，可用于治疗癌症，人类寄生虫，如肺囊虫病。
Artemisinin is also a promising potent drug in the treatment of cancer, human parasites such as pneumocystosis.
临床试验证实了青蒿素的抗疟效果。
In the early 1970s, a Project 523 team first isolated artemisinin from the plant. Clinical trials confirmed its antimalarial effects.
青蒿素耐药性出现的原因。
在收获或采收之后，叶中的青蒿素含量将逐步减少。
After harvesting or collection, the artemisinin content of the leaves will gradually decrease.
《控制青蒿素耐药性全球计划》中载有更全面的建议。
More comprehensive recommendations are available in the Global Plan for Artemisinin Resistance Containment (GPARC).
在防止脑型疟疾患儿死亡青蒿素衍生物并不次于奎宁。
Artemisinin derivatives are not inferior to quinine in preventing death in children with cerebral malaria.
多亏严密监测，沿泰柬边境发现了最初的青蒿素耐药迹象。
Thanks to intense surveillance, the first signs of resistance to artemisinin were detected along the Thai-Cambodian border.
这种联合被称为以青蒿素为基础的联合化疗（ACTs）。
These combinations are called artemisinin-based combination therapies (ACTs).
自那时以来，含青蒿素衍生物的产品的世界市场已迅速扩大。
Since then, the world market for products containing artemisinin derivatives has grown rapidly.
我可以毫不夸张地说，青蒿素耐药性广泛传播的后果将是灾难性的。
It is no exaggeration for me to say that the consequences of wide-spread resistance to artemisinins would be catastrophic.
我们必须禁止推销仅含青蒿素并因此缺少联合治疗双重打击力量的疗法。
We need to ban the marketing of therapies containing only artemisinin, and thus lacking that two-punch power of combination therapies.
如同大多数草药一样，青蒿素的含量和效力取决于气候、地理和环境条件。
As with most medicinal herbs, artemisinin's contents and efficacy are subject to climatic, geographical and environmental conditions.
以青蒿素为基础的新型联合疗法以及经长效杀虫剂处理的蚊帐已知很有效。
The new artemisinin-based combination therapies, and long-lasting insecticide-treated nets are known to be highly effective.
虽然感染患者在接受以青蒿素为基础的联合化疗之后痊愈，但恢复时间较长。
Although patients infected were cured following treatment with an artemisinin-based combination therapy (ACT), the recovery took more time.
在2009年2月，世卫组织证实在柬埔寨和泰国边界已出现对青蒿素的耐药性。
In February 2009, WHO confirmed that resistance to artemisinin had emerged on the Cambodia-Thailand border.
但是，有一些早期证据显示，对青蒿素的耐药性可能也正在缅甸和泰国的边界出现。
However, there is some early evidence that resistance to artemisinins may also be emerging on the Myanmar-Thailand border.
这是因为对最佳，也是最后一类有效抗疟药——青蒿素，产生耐药性所导致的失败。
This failure is due to resistance to artemisinin, our best and last class of effective antimalarials.
但是三种抗疟药——青蒿素、青蒿琥酯和蒿甲醚——栓剂的有效性从未进行过比较。
But the three types of antimalarial available in suppository form - artemisinin, artesunate and artemether - have never been compared for effectiveness.
2009年，大湄公河次区域，传统耐药疟疾的中心，确认出现对青蒿素的耐药性。
Resistance to artemisinins was confirmed in 2009 in the Greater Mekong subregion, the traditional epicentre for drug-resistant malaria.
问：为何您在青蒿素耐药性并未引起关注的时候就研究青蒿素类复方药呢？
Q: Why did you research ACT for malaria at a time when there were no concerns about resistance to artemisinin?
问：为何您在青蒿素耐药性并未引起关注的时候就研究青蒿素类复方药呢？
Q: Why did you research ACT for malaria at a time when there were no concerns about resistance to artemisinin?
应用推荐